1. WHO. Rapid Communication: Molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance. World Health Organization 2020; Policy upd: 1–8.
2. The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients;G Theron;Clin Infect Dis,2012
3. WHO Meeting Report of a Technical Expert Consultation: Non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF, http://apps.who.int/bookorders. (2017, accessed 12 January 2022).
4. The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda;A Andama;BMC Infect Dis,2021
5. 6. Tope Adepoyibi; 16th April 2013; Quality Assurance Proficiency testing for Xpert MTBRIF and other molecular methods.—Google Search.